Many knockoffs became popular when patients couldn’t find the brand-name medicines.
Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, threatening to upend the many knockoffs that became popular when patients couldn’t find the brand-name medicines.
The FDA first put the shortage classification in place at the end of 2022. That designation allowed compounding pharmacies to sell knockoff versions of the brand-name medicines — Mounjaro for diabetes, and Zepbound for obesity — without completing the same arduous testing process. These copycats have been widely available from medical spas and telehealth companies, often at a much lower cost.
“We know many people rely on our medicines, so we invested significantly to expand manufacturing and bring new options to the market,” Patrik Jonsson, executive vice president and president of Lilly Cardiometabolic Health and Lilly USA, said in an emailed statement. Compounding also attracted telehealth companies that marketed services to connect patients with health-care providers who can prescribe the drugs.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stockEli Lilly could be on its way to topping $1 trillion in market value. Meanwhile, Abbott launches its first over-the-counter continuous glucose monitor in U.S.
Read more »
Eli Lilly appoints insider Lucas Montarce as new finance chiefU.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately.
Read more »
Lilly Pulitzer jewelry, bags on sale for as low as $14Lilly Pulitzer is known for its bright colorful prints but the coastal chic line also has some amazing jewelry and small accessories as well.
Read more »
This 'The Matrix' Director Is Producing a New Dystopian Animated MovieLilly Wachowski
Read more »
Promotional Climate Impacts Oxford Industries’ Business in Q2The owner of Tommy Bahama, Lilly Pulitzer and Johnny Was lowered its guidance for fiscal 2024.
Read more »
Kidney failure patient shares warning about life-changing conditionLilly was put in an induced coma and rushed to intensive care in Bristol.
Read more »